Drug Week articles from August 2003

Drug Week archives from August 2003

New possibilities.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Research published by the Institute of Physics reports on a new technique that could in future help scientists working in rational drug design (a way of tailoring a new drug to fit the structure of the...

AMD473 (ZD0473) exhibits marked in vitro anticancer activity in human tumors.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- AMD473 (ZD0473) exhibits marked in vitro anticancer activity in human tumors. According to a study from the United States, "AMD473 (ZD0473; cis-amminedichloro[2-methylpyridine]-platinum [II]) is a...

Once-daily Adderall XR provides all-day symptom control for children.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- A study published in the Journal of the Academy of Child and Adolescent Psychiatry (JAACAP) shows that children with attention deficit hyperactivity disorder (ADHD) experienced significant control of...

Colorado biopharmaceutical company announces cardiac application of HDAC.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Myogen, Inc., a Colorado-based biopharmaceutical company, along with researchers at the University of Texas Southwestern Medical Center at Dallas, announced the first possible cardiac application of...

Patent announced for DNA vaccines with Vaxfectin adjuvant.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Vical, Inc., (VICL) announced the issuance of U.S. Patent No. 6,586,409, covering DNA vaccination with a novel adjuvant, Vaxfectin. Specific claims include compositions and methods for gene-based...

Azithromycin does not affect cyclosporine A pharmacokinetics after kidney transplantation.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Azithromycin does not affect the pharmacokinetics of cyclosporine A in kidney transplant recipients. "Some macrolide antibiotics have been shown to produce significant drug-drug interactions...

Thalidomide has moderate activity against chronic but not acute GVHD.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Thalidomide can be useful for the treatment of refractory chronic graft-versus-host reactions after stem cell transplantation, researchers in England say. ...

amfAR awards $1.5 million for basic research into HIV/AIDS.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- The American Foundation for AIDS Research (amfAR) announced nearly $1.5 million in basic research grants and fellowships for scientists working to understand and eliminate HIV/AIDS. "amfAR is...

Medical Services begins to fill contracts for VScan HIV Test Kits.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Medical Services International, Inc., (MSITF) announced that during June 2003 it shipped 17,000 test kits at an average price of $3.37 per kit. Based on contracts and existing orders the company...

UC San Diego collaborates on stroke clinical trial.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Innercool therapies announced it is collaborating with the University of California, San Diego (UCSD) Stroke Center in a clinical trial to improve the treatment of acute ischemic stroke patients. ...

Infant meconium components may expose women who drink during pregnancy.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Infant meconium components may expose women who drink during pregnancy. According to recent research published in the journal Therapeutic Drug Monitoring, "the detection of fatty acid ethyl esters...

Sirolimus extends delayed graft function substantially after kidney transplant.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Although sirolimus is not nephrotoxic, it does extend delayed graft function significantly in kidney transplants. "Sirolimus, lacking known nephrotoxicity, appeared to be an ideal immunosuppressive...

Oligohydrosis and fever reported in children treated with zonisamide.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Cases of oligohydrosis and fever have been reported in U.S. children treated with zonisamide. "Zonisamide is an antiepileptic drug developed and first marketed in Japan in 1989. Cases of...

Hemolysin-positive, drug-resistant A. hydrophila is a health threat.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- The incidence of Anisakis simplex in fish and shrimp, including hemolysin positive and antibacterial resistant strains, is high in coastal India and is a potential health threat. According to...

Compounds reverse age-related learning deficits in mice.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Eukarion, Inc., announced the publication of preclinical data showing that its synthetic catalytic scavenger (SCS) compounds reverse age-related learning deficits in mice. The data were published...

Promising findings reported from Alzhemed phase II study.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Neurochem, Inc., (NRM) announced a preliminary analysis of the data from its recently completed phase II clinical trial for the investigational drug candidate, Alzhemed, in patients with...

Study: Aricept therapy associated with delayed nursing home placement.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Persistent treatment with Aricept may help Alzheimer patients and their families by delaying entry into a nursing home. A recent study showed that dementia-related nursing home placement was...

CytRx licenses RNAi technology.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- CytRx Corporation (CYTR) announced it has signed an exclusive, worldwide, royalty-bearing license agreement with the University of Massachusetts Medical School (UMMS) to use UMMS's RNAi gene silencing...

Clots prompt warning over new stents.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Doctors got a stern warning to properly use a popular new drug-coated heart stent that has been linked to blood clots in almost 3 dozen people, including 5 who died. The Cypher stent is a tiny...

Berlin biotech starts clinical trial of a MIDGE-based DNA vaccine.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Mologen, a Berlin-based biotech company, has initiated a clinical trial to test the efficacy of a DNA vaccine to protect dogs against leishmaniasis. The study will take 7 months and is being...

First biologic recommended by FDA panel for inflammatory disease.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Amgen (AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (WYE), announced that Enbrel (etanercept) is the first biologic recommended for approval by the Arthritis Advisory Committee of the U.S. Food...

Effective mucosal immunity to anthrax obtained.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Neutralizing antibodies and Th cell responses to anthrax occurred after nasal immunization with protective antigen. According to a study from the United States, "Mucosal, but not parenteral,...

Danaparoid is successful in case of heparin induced skin reaction in pregnancy.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Synthetic heparinoid, danaparoid, is successful in case of heparin therapy-induced skin reactions during pregnancy. "Allergic cutaneous reactions to heparin are a diagnostic, but mainly therapeutic...

Hepatitis C virus nonstructural 5A protein attenuates interferon-linked signals.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Hepatitis C virus nonstructural 5A protein attenuates interferon-linked signals. "Alpha/beta interferons (IFN-alpha/beta) induce potent antiviral and antiproliferative responses and are used to...

FDA approves first humanized antibody that targets IgE.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Genentech, Inc., (DNA), Novartis Pharmaceuticals Corporation, an affiliate of Novartis AG (NVS), and Tanox, Inc., (TNOX) announced that the novel IgE-blocker Xolair (omalizumab) for subcutaneous use has...

Combination therapy is efficacious and does not increase airway inflammation.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Dual controller therapy for asthma is efficacious and does not increase airway inflammation. "Current guidelines for the treatment of moderate persistent asthma list the combination of long-acting...

Atherosclerosis found in normotensive obese women with low DHEA levels.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Early carotid atherosclerosis was found in normotensive severely obese premenopausal women with low levels of dehydroepiandrosterone (DHEA). According to recent research published in the Journal of...

Multiple-dose study of ETC-642 (RLT Peptide) begins.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Esperion Therapeutics, Inc., (ESPR), a biopharmaceutical company focused on discovering and developing HDL-targeted therapies for the treatment of cardiovascular disease, announced the initiation of a...

Focalin LA pivotal clinical trial initiated in adults with ADD/ADHD.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Celgene Corp. (CELG) announced that a pivotal clinical trial of Focalin LA (dexmethylphenidate hydrochloride extended-release capsules) in adults with attention deficit disorder/attention deficit...

Gene rearrangement could lead the way to a cure for systemic lupus.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Gene rearrangement could lead the way to a cure for systemic lupus. "Activation of T cells from patients with systemic lupus erythematosus (SLE) leads to increased signaling responses, detected by...

T cell response to live bacillus Calmette-Guerin mediated by CD1 molecules.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- The major CD8 T cell response to live bacillus Calmette-Guerin is mediated by CD1 molecules. "MHC class I-restricted CD8+ T cells are a crucial component of the host defense against mycobacterial...

Enterotoxigenic El Tor-like hemolysin produced by Vibrio fluvialis.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- An enterotoxigenic El Tor-like hemolysin produced by Vibrio fluvialis has been purified and characterized. According to a study from the United States, "The halophilic bacterium Vibrio fluvialis is...

Microspheres containing growth factor improve alginate scaffold vascularization.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Microspheres containing growth factor improve alginate scaffold vascularization. "Site-specific delivery of angiogenic growth factors from tissue-engineered devices should provide an efficient means...

Surface groups dictate polyamidoamine dendrimer molecular interactions.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Surface groups dictate PAMAM dendrimer molecular interactions. "Dendrimers are a new class of polymeric materials. They are globular, highly branched, monodisperse macromolecules. Due to their...

Cyclophosphamide is associated with an increased risk of bladder cancer.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Cyclophosphamide is associated with an increased risk of bladder cancer. According to a study from Canada, "Leiomyosarcoma of urinary bladder is rare, although it is the most common mesenchymal...

Cladribine and 2-chloro-adenosine induce apoptosis of human astrocytoma cells.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Cladribine and 2-chloro-adenosine induce apoptosis of human astrocytoma cells. "Both the anticancer agent 2-chloro-2'- deoxy-adenosine (Cladribine) and its derivative 2-chloro-adenosine induce...

A fusion protein with prolactin and angiogenesis antagonists snuffs out cancer.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Medical investigators have developed a fusion protein containing a prolactin antagonist and endostatin. It inhibits the growth of certain breast cancers. ...

Foundation comments on studies of high-dose chemo with stem-cell rescue.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Data from two clinical trials published in the July 3, 2003, issue of the New England Journal of Medicine explore potential benefits of high-dose chemotherapy with stem cell rescue in the treatment of...

HRG/M sequences are sufficient to sensitize MCF-7 cells to doxorubicin.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- HRG/M sequences are sufficient to sensitize MCF-7 cells to doxorubicin. According to a study from the United States, "Heregulin (HRG) is an activator of the erbB2-, erbB3- and erB4-(erbB-2/3/4)...

Increased dose intensity of chemotherapy did not increase efficacy.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Increased dose intensity of chemotherapy did not increase efficacy. "The purpose of this multicenter phase III trial was to assess the impact of a time-intensification of FEC (fluorouracil,...

Low-dose tamoxifen may be effective treatment, with fewer side effects.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Administering tamoxifen at lower doses than the current standard dose appears to effectively reduce breast cancer proliferation while causing fewer side effects, researchers reported at the 2003 Annual...

NSAIDs may block development of breast tumors.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Regular use of ibuprofen and aspirin inhibits the formation and growth of breast cancer, according to data from the National Cancer Institute's (NCI) Women's Health Initiative (WHI) Observational Study....

Novel murine model enables bone marrow transplantation evaluation.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- A novel murine model of breast cancer will aid the evaluation of bone marrow transplantation as therapy. Scientists in the United States developed a "breast cancer model in rats, in which...

Prolactin may be a novel therapeutic target for the treatment of breast cancer.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Prolactin may be a novel therapeutic target for the treatment of breast cancer. According to a study from the United States, "Prolactin (PRL) is an important hormone in mammary tumorigenesis in...

Tamoxifen induces apoptosis in breast cancer cells.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Tamoxifen induces apoptosis in breast cancer cells. According to recent research from South Korea, "Tamoxifen (TAM) is the endocrine therapeutic agent the most widely used in the treatment of...

VEGF falls short for predicting outcomes in certain metastatic breast cancers.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- VEGF falls short for predicting outcomes in certain metastatic breast cancers. "Prediction of survival for patients with metastatic breast cancer is often inaccurate and may be helped by new...

New generation of treatments shows promise for cancer patients.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Armed with information about the function and capabilities of currently approved cancer therapies, researchers are beginning to develop more potent and successful treatments, according to research...

CXCR-4 clinical antibodies identified.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Northwest Biotherapeutics, Inc., (NWBT) announced the completion of its in-vitro preclinical assessment of a battery of proprietary monoclonal antibodies directed against the cancer associated target...

Novel compound inhibits paclitaxel- and docetaxel-resistant tumor cell lines.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- A novel taxane inhibits the growth of paclitaxel- and docetaxel-resistant tumor cell lines, according to data presented at the 94th Annual Meeting of the American Association for Cancer Research (AACR)...

Phase I clinical trial of MLN944 launched.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Millennium Pharmaceuticals, Inc., (MLNM) and Xenova Group, plc, (XNVA) announced the initiation of a phase I clinical trial of MLN944 (also known as XR5944). MLN944 is a DNA targeting agent under...

Study of Dacogen (decitabine) in combination with carboplatin launched.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- SuperGen, Inc., (SUPG) and Cancer Research UK announced the initiation of a phase I/II clinical study of Dacogen (decitabine), in combination with carboplatin, in cancer patients with advanced solid...

Hyperthermia improves immune response to human hepatocellular carcinoma.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Hyperthermia improved the cellular immune response to human hepatocellular carcinoma subsequent to co-culture with tumor lysate pulsed dendritic cells. "Dendritic cells play a major role in cellular...

LAG-3 enables DNA vaccination to prevent breast cancer in mice.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Lymphocyte activation gene-3/CD223 (LAG-3) enabled DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice. According to a study from Italy, "Within 33...

Measles virus producing carcinoembryonic antigen fights glioblastoma.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- A vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen has been used as a novel therapeutic agent against glioblastoma multiforme. According to published...

Vaccine with fusion cells of dendritic and carcinoma cells halts tumor growth.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Vaccination with fusion cells of rat dendritic and carcinoma cells prevented tumor growth in vivo. According to a study from Japan, "Several reports on immunotherapy using dendritic cells-based...

HIV inactivates the body's cellular smart bomb.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- HIV eludes one of the body's key smart bomb defenses against infection, and this finding may lay the groundwork for new drugs to treat AIDS, according to a new Salk Institute study. Nathaniel...

Some cytokines inactivate VEGF signals by controlling its receptors.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Some cytokines inactivate VEGF signals by controlling its receptors. "Confluent endothelial cells respond poorly to the proliferative signals of VEGF. Comparing isogenic endothelial cells differing...

Current botulinum toxin treatment appears to be nonimmunogenic.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- A comparison of original and current botulinum toxin for treatment of cervical dystonia reveals there appears to be no more antibody reactivity risk. "The authors compared 130 patients treated for...

Institute for Oneworld Health licenses potent therapy.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- The Institute for OneWorld Health, the first nonprofit pharmaceutical company in the United States, has licensed a novel class of high-potency compounds from Yale University and the University of...

Delayed nausea common for cancer patients.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Many more cancer patients who receive chemotherapy report a serious problem with nausea a day or two later than on the day of their treatment, according to a new study. The report showed that...

Hepatitis C virus clears spontaneously upon immunosuppression discontinuation.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Hepatitis C virus clears spontaneously upon immunosuppression discontinuation. "Approximately 85% of acute cases of hepatitis C infection result in chronic hepatitis. Spontaneous clearance of...

European committee grants positive opinion on survival claim for MabCampath.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Schering AG, Germany, (SHR; SCH) and ILEX Oncology, Inc., (ILXO) announced that the European Committee for Proprietary Medicinal Products (CPMP) has granted a positive opinion on the addition of...

FDA grants fast track designation for Genasense in CLL.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Genta, Inc., (GNTA) announced that the U.S. Food and Drug Administration (FDA) has designated Genasense (oblimersen sodium) as a "fast track" product for the treatment of patients with chronic...

Pivotal phase III study of Oxytrex launched.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Pain Therapeutics, Inc., (PTIE) announced the initiation of a phase III clinical study with Oxytrex, the company's investigational new drug to treat chronic pain. This pivotal study will enroll up...

Alliance formed to promote cardiac safety services.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- eResearchTechnology (eRT), Inc., (ERES), a provider of centralized electrocardiographic (ECG) collection and interpretation services, announced it has entered into an agreement with California Clinical...

Commercial option exercised for HuMax-IL15.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Genmab A/S announced that Amgen has exercised its commercialization options for both the HuMax-IL15 antibody program and the IL15 receptor program. In addition, Amgen has expanded its agreement with...

Diagnostic biomarker discovery program initiated.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Ciphergen Biosystems, Inc., (CIPH) announced that it has established a diagnostic biomarker discovery collaboration with bioMerieux S.A. by which the two companies will work together to discover...

Medicinal chemistry agreement signed for development of kinase target.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Evotec OAI (EVT) and Axxima Pharmaceuticals AG announced that they have entered into a medicinal chemistry agreement to design and synthesize small molecule lead structures for one of Axxima's leading...

Pharmaceutical firm, Duke University announce drug discovery alliance.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Provid Pharmaceuticals, Inc., and the Duke University Medical Center Division of Neurology have announced the initiation of a collaboration to identify compounds that could be of value in the treatment...

Studies demonstrate differing response from left and right colon tumors.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Significant genetic differences exist between tumors of the right and left side of the colon, according to data presented at the 94th Annual Meeting of the American Association for Cancer Research...

Older drug could have exciting new role.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Researchers at Wake Forest University Baptist Medical Center are reporting how a 15-year-old drug could have a promising new role in the treatment of rectal cancer. The drug is oxaliplatin, and when...

Pharmaceutical compliance firm to use Documentum platform.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Documentum (DCTM), a provider of enterprise content management (ECM), announced that Laboratory Management Systems, Inc., (LMSi), a full-service laboratory compliance partner for global pharmaceutical...

STAAR Surgical PMA granted expedited review status by FDA.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- STAAR Surgical Co. (STAA), a developer, manufacturer, and marketer of minimally invasive ophthalmic products, announced that the premarket approval application (PMA) for its implantable contact lens...

Emergency contraceptive levonorgestrel won't stop postfertilization activity.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- The emergency contraceptive levonorgestrel won't stop postfertilization activity. "Levonorgestrel (LNG), a progestin widely used for regular hormonal contraception, is also used for emergency...

Survey reveals what women want in a birth control pill.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- According to recent surveys commissioned by Ortho-McNeil Pharmaceutical, Inc., maker of Ortho Tri-Cyclen Lo (norgestimate/ethinyl estradiol) Tablets and the U.S. leader in women's healthcare products,...

Biotech firm completes move to new headquarters.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Corgentech, Inc., announced that it has moved its corporate headquarters from Palo Alto to new space at 650 Gateway Boulevard in South San Francisco, California, 94080. The new South San Francisco...

Global Path changes name.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Global Path Inc.'s previously announced name change to Swiss Medica, Inc., (SWME) is now effective. The name change was approved by written consent of the board of directors and the holders of a...

Hypermutable Staphylococcus aureus strains common in patients.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Cystic fibrosis (CF) patients commonly carry hypermutable strains of staphylococcal pathogens. "Incidence of resistance to erythromycin at our institution reached 53% in 122 Staphylococcus aureus...

Generic alternative to Cytovene approved by FDA.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Ranbaxy Pharmaceuticals, Inc., (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced that RLL has received approval from the U.S. Food and Drug Administration to manufacture...

DNA vaccines for the rabies-related virus, Mokola, compared.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- DNA vaccines for the rabies-related virus, Mokola, were compared. According to published research from the United States, "Mokola virus, a rabies-related virus, has been reported to date from the...

Drug-inducible, dendritic cell-based genetic immunization accomplished.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Greater immunological control is possible through drug-inducible, dendritic cell-based genetic immunization. "Determining the mechanism of antigen loading of Langerhans cells (LC) for genetic...

A new skin cancer model should contribute to the study of antiangiogenic therapy.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- A new skin cancer model should contribute to the study of antiangiogenic therapy. According to a study from the United States, "tumor angiogenesis is governed by a complex balance of positive and...

Imiquimod is a broadly reactive, antiviral, immunostimulatory topical agent.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Imiquimod is a topical agent that is immunostimulatory, capable of treating a wide variety of dermatological infections and possibly even cancer. According to recent research from the United States,...

Olux approved for marketing in the United Kingdom.
August 1, 2003... 2003 AUG 1 - (NewsRx.com & NewsRx.net) -- Connetics Corporation (CNCT) announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom has granted marketing authorization for Olux (clobetasol propionate)...